12 April 2018 EMA/234056/2018 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: clindamycin phosphate / tretinoin

Procedure no.: PSUSA/00010080/201707

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Product Name (in

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

authorisation country)

number

Number

member state

product is authorised

Acnatac 10mg/g + 0,25mg/g

SE/H/1134/001

85210.00.00

MEDA PHARMA GMBH & CO.

DE

Gel Acnatac 10 mg/g + 0,25 mg/g

KG SE/H/1134/001

74775/18-11-2014

SE/H/1134/001

15/202/13-C

MEDA PHARMA S.R.O.

CZ

SE/H/1134/001

29824

MEDA OY

FI

SE/H/1134/001

21435

MEDA PHARMA GMBH & CO.

PL

γέλη Acnatac 10 mg/g + 0,25 mg/g

MEDA PHARMACEUTICALS

GR

S.A.

gel Acnatac 10 mg/g + 0,25 mg/g geeli Acnatac , (10 mg + 0,25 mg)/g, żel

KG

Acnatac

SE/H/1134/01/DC

48954

MEDA AS

DK

Acnatac 10mg/g + 0,25mg/g gel

SE/H/1134/001

5585831

MEDA PHARMA – PRODUTOS

PT

FARMACÊUTICOS, S.A. Acnatac 10mg/g + 0,25mg/g gel

SE/H/1134/001

5585823

MEDA PHARMA – PRODUTOS

PT

FARMACÊUTICOS, S.A. Acnatac 10 mg/g + 0,25 mg/g

SE/H/1134/001

021888

γέλη Acnatac 10 mg/g + 0,25 mg/g

MEDA PHARMACEUTICALS

CY

S.A. SE/H/1134/001

46/0464/13-S

MEDA PHARMA SPOL. S R.O.

SK

Acnex 10mg/g+0,25mg/g gél

SE/H/1134/001

OGYI-T-22460/01

MEDA PHARMA HUNGARY

HU

ACNATAC 10 mg/g + 0,25

SE/H/1134/001

042056022

MEDA PHARMA S.P.A.

IT

SE/H/1134/001

46193

MEDA AB

SE

SE/H/1134/001

042056010

MEDA PHARMA S.P.A.

IT

SE/H/1134/001

812213

MEDA PHARMA SIA

EE

gél KFT. mg/g gel Acnatac 10 mg/g + 0,25 mg/g, gel ACNATAC 10 mg/g + 0,25 mg/g gel Treclinac 10 mg/0,25 mg/g geel

List of nationally authorised medicinal products EMA/234056/2018

Page 2/4

Product Name (in

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

authorisation country)

number

Number

member state

product is authorised

Treclin 1 %/0.025 % w/w gel

SE/H/1134/001

MA806/01101

MEDA PHARMACEUTICALS

MT

LTD Treclin 1 %/0.025 % w/w gel

SE/H/1134/001

PL 15142/0249

MEDA PHARMACEUTICALS

UK

Treclinac 0,25 mg/g + 10 mg/g,

SE/H/1134/001

RVG 109745

MEDA PHARMA B.V.

NL

ZANEA 10 mg/0,25 mg, gel

SE/H/1134/001

34009 277 382 9 6

MEDA PHARMA SAS

FR

ZANEA 10 mg/0,25 mg, gel

SE/H/1134/001

34009 277 381 2 8

MEDA PHARMA SAS

FR

Treclinac 10 mg/ 0,25 mg/g gels

SE/H/1134/001

13-0090

MEDA PHARMA SIA

LV

Acnatac 10 mg/g + 0,25 mg/g

SE/H/1134/001

5669/2013/01

MEDA PHARMA GMBH & CO.

RO

LTD gel

gel

KG

Treclinac 10 mg/0,25 mg/g gelis

SE/H/1134/001

LT/1/13/3279/001

MEDA PHARMA SIA

LT

Acnatac 10 mg/g + 0,25 mg/g

SE/H/1134/001

1-31861

MEDA PHARMA GMBH

AT

SE/H/1134/001

PA1332/043/001

MEDA HEALTH SALES

IE

Gel Treclin 1 % / 0.025 % w/w Gel

IRELAND LIMITED Treclinax 10 mg/g + 0,25 mg/g

SE/H/1134/001

BE437507

S.A. MEDA PHARMA N.V.

BE

SE/H/1134/001

2013/110425

S.A. MEDA PHARMA N.V.

LU

SE/H/1134/001

BE437507

S.A. MEDA PHARMA N.V.

BE

Zalna 10 mg/g/0,25 mg/g gel

SE/H/1134/001

11-8356

MEDA AS

NO

Zalna 10 mg/0,25 mg v 1 g gel

SE/H/1134/001

H/13/01693/001

MEDA PHARMA GMBH & CO.

SI

Акнатак 10 mg/g + 0,25 mg/g

SE/H/1134/001/DC

20130224

MEDA PHARMA GMBH & CO.

SE/H/1134/001

IS/1/13/032/01

MEDA AB

gel Treclinax 10 mg/g + 0,25 mg/g gel Treclinax 10 mg/g + 0,25 mg/g gel

KG гел Acnatac 10mg/g +0,25mg/g

BG

KG IS

hlaup List of nationally authorised medicinal products EMA/234056/2018

Page 3/4

Product Name (in

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

authorisation country)

number

Number

member state

product is authorised

Zalna 10 mg/0,25 mg v 1 g gel

SE/H/1134/001

H/13/01693/002

MEDA PHARMA GMBH & CO.

SI

KG Acnatac 10 mg/g + 0,25 mg/g

SE/H/1134/001

29824

MEDA OY

FI

SE/H/1134/001

BE437507

S.A. MEDA PHARMA N.V.

BE

SE/H/1134/001

2013/110425

S.A. MEDA PHARMA N.V.

LU

SE/H/1134/001

77.481

MEDA PHARMA S.L.

ES

SE/H/1134/001

5669/2013/02

MEDA PHARMA GMBH & CO.

RO

gel Treclinax 10 mg/g + 0,25 mg/g Gel Treclinax 10 mg/g + 0,25 mg/g Gel TRECLINAC 10 mg/g + 0,25 mg/g Gel* Acnatac 10 mg/g + 0,25 mg/g gel Acnex 10mg/g+0,25mg/g gél

KG SE/H/1134/001

OGYI-T-22460/02

MEDA PHARMA HUNGARY

HU

KFT.

List of nationally authorised medicinal products EMA/234056/2018

Page 4/4

PSUSA/00010080/201707 - European Medicines Agency - Europa EU

Apr 12, 2018 - Human Medicines Evaluation Division. List of nationally authorised medicinal products ... List of nationally authorised medicinal products. EMA/234056/2018. Page 3/4. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the member ...

95KB Sizes 34 Downloads 149 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...